Paper Details

Paper Title

Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.

Paper Journal Title

EClinicalMedicine

Paper Citation Count

Paper Publication Year

2021

Bio Mention

Mesh Descriptor

Author Name	Affiliation
John C O'Horo	Mayo Clinic
Sidna M Tulledge-Scheitel	Mayo Clinic
Ravindra Ganesh	Mayo Clinic

1 - 3

Paper Details

Column Actions

Datasets